CHCT Q1 2026 Earnings Call Transcript

Community Healthcare Trust reported Q1 revenue of $31.5 million, up 4.8% year over year, with FFO rising 5.8% to $13.4 million and AFFO up 4.1% to $15.4 million. Occupancy fell to 89.8% from 90.6%, but the company raised its dividend to $0.48 per share and highlighted a $28.5 million acquisition plus $99 million of signed pipeline deals at 9.1% to 9.75% expected yields. Management expects second-quarter interest expense to increase after $75 million of hedges expired and due to higher revolver use.

Analysis

CHCT is in a classic self-help phase where reported growth is being masked by portfolio pruning and temporary occupancy slippage. The important second-order effect is that management is deliberately swapping lower-quality, slower-growing assets for higher-yielding redeployments while avoiding equity issuance; that should support per-share value if execution is clean, but it also makes near-term results look softer than the underlying earnings power. The market will likely underappreciate how much of the current margin pressure is timing-driven versus structural, especially if the redevelopment assets start contributing in the back half of the year.

The real risk is financing drift. With hedge protection rolling off and revolver utilization rising, incremental debt cost will likely outpace the yield on older assets that were underwritten in a lower-rate era, so CHCT needs dispositions to stay ahead of funding costs. If the behavioral tenant transaction slips again, investors will start assigning a higher probability to residual rent leakage and re-tenanting friction, which could compress the multiple faster than the fundamentals deteriorate.

The contrarian angle is that the stock may be penalizing the wrong variable: occupancy is the visible metric, but AFFO per share is the better signal, and that should re-accelerate once redevelopment starts contributing and acquisition proceeds are deployed. The private-market bid for healthcare real estate still appears intact, but CHCT is choosing to be selective; that tends to look like underinvestment in the short term and disciplined capital allocation in the long term. If the company can keep recycling into 9%+ cash yields while maintaining modest leverage, the dividend step-up could become a credibility catalyst rather than a yield trap.

Key Decisions for Investors

• Long CHCT on weakness over the next 1-3 months: risk/reward improves if the market over-discounts the occupancy dip and higher interest expense; target a re-rating into the next print if leased occupancy inflects and the behavioral tenant update turns constructive.
• Buy CHCT Jan-2027 calls or call spreads: this is a time-lag story, and the upside is more likely to show up over 6-12 months as redevelopments commence NOI and acquisitions are funded from asset sales rather than dilution.
• Pair trade: long CHCT / short a higher-leverage healthcare REIT with more rate sensitivity over the next quarter; CHCT’s self-funded growth and shorter lease-duration risk should outperform if credit markets stay tight.
• If already long, hedge with near-dated put spreads into the next quarter: the main downside catalyst is another delay in the behavioral tenant transaction combined with a bigger-than-expected jump in interest expense.
• Avoid chasing strength until disposition cadence and redevelopment timing are visible; the stock likely needs one clean quarter of AFFO-per-share stability before the market prices the capital recycling strategy as accretive rather than defensive.